Grf analogs v

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530/7.1, 167/103

C07K 14/60 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1304193

GRF ANALOGS V ABSTRACT OF THE DISCLOSURE The invention provides peptides which are particularly potent in stimulating the release of pituitary GH in fish and amphibians and which have a substantial portion or all of the following sequence: His-Ala-Asp-Gly-R5- Phe-Asn-Lys-Ala-Tyr-Arg-Lys-Ala-Leu-Gly-Gln-Leu-Ser-Ala- Arg-Lys-Tyr-Leu-His-Thr-Leu-R27-R28-R29-R30-R31-Gly-R33- R34-R35-R36-R37-R38-R39-R40-R41-R42-R43-R44-Ser wherein R5 is Met, Leu, Val, Nva, Gln, Thr, Ile or Nle; R27 is Met, Leu, Val, Nva, Gln, Thr, Ile or Nle; R28 is Ala, Ser or Asn; R29 is Lys or Arg; R30 is Arg or Gln; R31 is Val or Gln; R33 is Gly or Glu; R34 is Gly, Arg or Ser; R35 is Ser or Asn; R36 is Met, Leu, Val, Nva, Gln, Thr, Ile or Nle; R37 is Ile or Glu; R38 is Glu, Gln or Arg; R39 is Asp, Arg or Gly; R40 is Asp, Ser or Ala; R41 is Asn, Arg or Lys; R42 is Glu, Phe, Ala or Val; R43 is Pro, Asn or Arg; R44 is Leu or Ala. A sequence beginning at the C-terminus and extending part way or all the way to residue R27 may be deleted; a 29-residue peptide beginning at the N-terminus may be preferred. These peptides, as well as their nontoxic salts, are considered to be particularly useful in aquiculture.

556019

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Grf analogs v does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Grf analogs v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Grf analogs v will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1242421

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.